Harness Therapeutics

Cambridge, United Kingdom

Harness Therapeutics is a developer of a platform for physiological upregulation of proteins using targeted translation enhancers, SINEUPs.

Jun 2026

Grant

Biotechnology Life Science

Top Investors

Michael J. Fox FoundationDementia Discovery FundSV Health InvestorsOno Venture InvestmentEpidarex Capital

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Harness Therapeutics

Who are Harness Therapeutics's investors?

Harness Therapeutics's investors include Michael J. Fox Foundation, Dementia Discovery Fund, SV Health Investors, Ono Venture Investment, Epidarex Capital.

Where is Harness Therapeutics headquartered?

Harness Therapeutics is headquartered in Cambridge, United Kingdom.

What does Harness Therapeutics do?

Harness Therapeutics is a developer of a platform for physiological upregulation of proteins using targeted translation enhancers, SINEUPs.

What stage is Harness Therapeutics at?

Harness Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 9, 2026.

MLA

"Harness Therapeutics — Funding & Investors." VCBacked, June 9, 2026, https://www.vcbacked.co/company/harness-therapeutics. Accessed June 30, 2026.

APA

VCBacked. (2026). Harness Therapeutics — Funding & Investors. Retrieved June 30, 2026, from https://www.vcbacked.co/company/harness-therapeutics

Wikipedia (cite web)

{{cite web |title=Harness Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/harness-therapeutics |website=VCBacked |access-date=June 30, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 9, 2026.